1 Correction to: Drugs (2019) 79:325–329 https://doi.org/10.1007/s40265-019-1053-4
The article Sarecycline: First Global Approval, written by Emma D. Deeks, was originally published Online First without open access. After publication in volume 79, issue 3, pages 325–329 Almirall, LLC., requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Almirall, LLC. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. Additional information for this AdisInsight Report has also been added and can be found at https://doi.org/10.6084/m9.figshare.8029316.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Deeks, E.D. Correction to: Sarecycline: First Global Approval. Drugs 79, 795 (2019). https://doi.org/10.1007/s40265-019-01122-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-019-01122-z